Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Second meningococcal vaccination in Dutch children: MenACWY-TT versus MenC-TT
2013-001823-38Phase 4Completed
- Sponsor
- National Institute for Public Health and the Environment
- Start
- Aug 2013
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Phase 4 trial of Meningococcal polysaccharide vaccine group W-135 and Meningococcal group C polysaccharide conjugate vaccine in meningococcal disease (2 arms), sponsored by National Institute for Public Health and the Environment. Started Aug 2013; status: completed.
02
Drugs
Meningococcal polysaccharide vaccine group W-135Meningococcal group C polysaccharide conjugate vaccine
03
Conditions
meningococcal disease
Beyond the preview
Go deeper on 2013-001823-38.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2013-001823-38.